NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘biopharmaceutical’

4 March 2015

OrbiMed leads weighty $30m round in biopharmaceutical Tricida

download (65) Venture capital firm OrbiMed has led a $30m Series B financing round in San Francisco-based biopharmaceutical company Tricida.

3 March 2015

Rock Springs, Sofinnova in cool $70m Series E for biopharma company Chiasma

syringe-m Venture capital investors Rock Springs Capital and Sofinnova Ventures have taken part in a sizable $70m funding round for US biopharmaceutical Chiasma.

23 February 2015

VC-backed Heptares Therapeutics sold to Japanese trade partner for $400m

sold-sale-exit-deal UK biopharmaceutical Heptares Therapeutics, whose backers have included MVM Life Science Partners, Novartis Venture Fund and Takeda Ventures, has been sold to Tokyo-listed pharma company Sosei Group Corporation.

28 January 2015

VC-backed Zosano Pharma launches IPO

Pharmedium drugs Venture capital-backed biopharmaceutical company Zosano Pharma has launched for an Intial public offering, pricing its 4.5 million shares at $11 per share.

2 January 2015

Aperture reels in nearly $50m for third health-care fund

health healthcare drugs pills medication medical New York-based investor Aperture Venture Partners has reeled in nearly half of its $100m target for its third fund health-care fund, AltAssets can reveal.

22 October 2014

Brandon Point, Woodford in Series D round for biopharmaceutical

fungus-3-1411424-m UK fund manager Woodford Investment Management and Brandon Point Industries have provided $60m Series D financing for antifungal research company Viamet Pharmaceuticals Holdings.

14 October 2014

Cancer, virus treatment business Rigontec nets €9.45m VC-backed Series A

cells5_sq Wellington Partners and Boehringer Ingelheim Venture Fund have co-led a €9.45m Series A financing round for cancer and virus-focused biopharma business Rigontec.

26 August 2014

Sofinnova, Rock Springs in $55m Series C for Parkinson’s relief pharma company

luxurary-74895-m Sofinnova Ventures, Rock Springs Capital and Adage Capital Management are among new investors in a sizable $55m funding round for biopharmaceutical company Civitas Therapeutics.

5 August 2014

Healthcare Royalty Partners pulls in more than $1bn for Fund IIIp

crown royalty Global investment firm Healthcare Royalty Partners has gathered more than $1bn towards its latest vehicle targeting innovative biopharmaceutical businesses in Europe, the US and Asia.

19 May 2014

US biopharma Proteon Therapeutics raises $45m Series D

US biopharmaceutical company Proteon Therapeutics has closed a $45m of Series D equity financing, including a $25m tranche to fully fund the first Phase 3 clinical study of its lead product.

Page 1 of 612345...Last »

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015